NMPA

Explore the landscape of NMPA in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on NMPA to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Novo Nordisk Licenses Hengrui's HRS‑1596 in Up to USD 2.6 Billion Global Deal – Once‑Weekly Oral Candidate for Obesity and Type 2 Diabetes
CompanyDeals

Novo Nordisk Licenses Hengrui’s HRS‑1596 in Up to USD 2.6 Billion Global Deal – Once‑Weekly Oral Candidate for Obesity and Type 2 Diabetes

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276; HKG: 1276) announced a licensing agreement with Novo Nordisk A/S (NYSE: NVO) for HRS‑1596, an oral candidate with once‑weekly administration potential targeting obesity,…

Novo Nordisk Licenses Nanexa's PharmaShell Platform in Up to EUR 1.165 Billion Global Deal – Targeting Monthly and Quarterly Long‑Acting Injectables for Obesity and Type 2 Diabetes

Novo Nordisk Licenses Nanexa’s PharmaShell Platform in Up to EUR 1.165 Billion Global Deal – Targeting Monthly and Quarterly Long‑Acting Injectables for Obesity and Type 2 Diabetes

European Commission Revokes Hansoh's Aumolertinib Marketing Authorization – EU Approval Reversed Seven Months After Grant in TAGRISSO Data‑Protection Dispute

European Commission Revokes Hansoh’s Aumolertinib Marketing Authorization – EU Approval Reversed Seven Months After Grant in TAGRISSO Data‑Protection Dispute

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Policy / Regulatory

CDE Introduces New Guidelines for Generic Drug Quality and Efficacy Consistency Evaluation

Policy / Regulatory

NMPA Seeks Comments on Medical Device Classification Draft Proposal

CompanyDrug

Chongqing Lummy Pharmaceutical’s Subsidiary Receives NMPA Approval for CUD002 mRNA Vaccine

Policy / Regulatory

CDE Annual Report: Clinical Trials for Innovative Drugs in China Reach Record High

Policy / Regulatory

NMPA Drafts Guidelines for Supervising Online Drug Exchange Platforms

Policy / Regulatory

Taizhou Port Designated as Drug Import Port by NMPA and General Administration of Customs

Policy / Regulatory

Li Li Appointed as New Director of NMPA

Policy / Regulatory

NMPA Revises Drug Conditional Approval Procedures: Streamlined Processes and Requirements

Show More